Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age

Julkaisu

Reference

Vesikari T, Block SL, Guerra F, et al. Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age. Pediatr Infect Dis J 2012:31(5):494-500.

Julkaisutiedot

Julkaisutyyppi: Alkuperäisartikkeli.
Kansainvälinen.
Kieli: Englanti.

Teksti/tiivistelmä: https://www.ncbi.nlm.nih.gov/pubmed/22301476

Publication data

Publication type: Original scientific article.
International.
In English.

Text/summary: https://www.ncbi.nlm.nih.gov/pubmed/22301476

Tekijät

Contributors

Tampereen yliopisto

Lääketieteen laitos/virologia 1
- Timo Vesikari

University of Tampere

Medical School/Department of Virology 1
- Timo Vesikari

Tampereen yliopistollinen sairaala

Lastentautien vastuualue
- Timo Vesikari

Tampere University Hospital

Julkaisutietokanta 8.1.2013

Publications Data Base 8.1.2013